AUTHORS: Amrit Kaliasethi, Tia Kwong, Mariam Bibi OBJECTIVES In 2013, England’s National Ins...
Read moreThe recent appraisal by the National Institute for Health and Care Excellence (NICE) for Iptacopan, ...
Read moreWe explore whether including the patient voice in early stages of drug development optimises patient...
Read moreKey findings from the ABPI's latest report highlight challenges and opportunities in NICE's health t...
Read moreAs the focus on sustainability grows, manufacturers will need to address their products’ environme...
Read moreScottish Medicines Consortium approves the use of obesity treatment under the NHS in UK first, whils...
Read moreNHS and NICE propose faster adoption of MedTech, streamlining funding and market access for innovati...
Read moreNHS takes a bold step towards achieving net zero by decommissioning desflurane due to its high globa...
Read moreWe discuss the 2024 VPAG agreement, how it differs from the previous VPAS and whether this will impa...
Read moreWebinar: Discussions on the new Voluntary Scheme for Branded Medicines, Pricing, Access and Growth (...
Read more